Neuropeptide Y

A Novel Angiogenic Factor From the Sympathetic Nerves and Endothelium

From the Departments of Physiology and Biophysics (Z.Z.-G., E.K.-P., S.M., H.J.), Obstetrics and Gynecology (J.R.), and Cell Biology (Y.Y., W.-T.C.), Georgetown University Medical Center, Washington, DC; Cell Biology Section, National Institute of Dental Research, Bethesda, Md (H.K.K.); Cardeza Foundation for Hematological Research, Jefferson University, Philadelphia, Pa (W.R., D.S.G.); and Department of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (E.G.).

Correspondence to Zofia Zukowska-Grojec, Department of Physiology and Biophysics, Georgetown University Medical Center, 3900 Reservoir Rd NW, Washington, DC 20007. E-mail zzukow01{at}medlib.georgetown.edu

Abstract—Sympathetic nerves have long been suspected of trophic activity, but the nature of their angiogenic factor has not been determined. Neuropeptide Y (NPY), a sympathetic cotransmitter, is the most abundant peptide in the heart and the brain. It is released during nerve activation and ischemia and causes vasoconstriction and smooth muscle cell proliferation. Here we report the first evidence that NPY is angiogenic. At low physiological concentrations, in vitro, it promotes vessel sprouting and adhesion, migration, proliferation, and capillary tube formation by human endothelial cells. In vivo, in a murine angiogenic assay, NPY is angiogenic and is as potent as a basic fibroblast growth factor. The NPY action is specific and is mediated by Y1 and Y2 receptors. The expression of both receptors is upregulated during cell growth; however, Y2 appears to be the main NPY angiogenic receptor. Its upregulation parallels the NPY-induced capillary tube formation on reconstituted basement membrane (Matrigel); the Y2 agonist mimics the tube-forming activity of NPY, whereas the Y2 antagonist blocks it. Endothelium contains not only NPY receptors but also peptide itself, its mRNA, and the "NPY-converting enzyme" dipeptidyl peptidase IV (both protein and mRNA), which terminates the Y1 activity of NPY and cleaves the Tyr¹-Pro² from NPY to form an angiogenic Y2 agonist, NPY_3–36. Endothelium is thus not only the site of action of NPY but also the origin of the autocrine NPY system, which, together with the sympathetic nerves, may be important in angiogenesis during tissue development and repair.

Key Words: angiogenesis • chemotaxis • dipeptidyl peptidase IV • NPY receptor • endothelial cell

This article has been cited by other articles:

				D. H. Damon TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3 Am J Physiol Cell Physiol, January 1, 2008; 294(1): C306 - C312. [Abstract] [Full Text] [PDF]

				E. Y. Callanan, E. W. Lee, J. U. Tilan, J. Winaver, A. Haramati, S. E. Mulroney, and Z. Zukowska Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1811 - F1817. [Abstract] [Full Text] [PDF]

				M. Egger, W. Schgoer, A. G. E. Beer, J. Jeschke, J. Leierer, M. Theurl, S. Frauscher, O. M. Tepper, A. Niederwanger, A. Ritsch, et al. Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1{alpha}- and basic FGF-dependent pathway in muscle cells FASEB J, September 1, 2007; 21(11): 2906 - 2917. [Abstract] [Full Text] [PDF]

				Z.-Y. Chen, G.-G. Feng, K. Nishiwaki, Y. Shimada, Y. Fujiwara, T. Komatsu, and N. Ishikawa Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transduction Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H959 - H967. [Abstract] [Full Text] [PDF]

				D. Ribatti, M. T. Conconi, and G. G. Nussdorfer Nonclassic Endogenous Novel Regulators of Angiogenesis Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205. [Abstract] [Full Text] [PDF]

				S. Movafagh, J. P. Hobson, S. Spiegel, H. K. Kleinman, and Z. Zukowska Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors FASEB J, September 1, 2006; 20(11): 1924 - 1926. [Abstract] [Full Text] [PDF]

				G. Ghersi, Q. Zhao, M. Salamone, Y. Yeh, S. Zucker, and W.-T. Chen The Protease Complex Consisting of Dipeptidyl Peptidase IV and Seprase Plays a Role in the Migration and Invasion of Human Endothelial Cells in Collagenous Matrices. Cancer Res., May 1, 2006; 66(9): 4652 - 4661. [Abstract] [Full Text] [PDF]

				V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax Pericellular Proteases in Angiogenesis and Vasculogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728. [Abstract] [Full Text] [PDF]

				M. Ruscica, E. Dozio, S. Boghossian, G. Bovo, V. Martos Riano, M. Motta, and P. Magni Activation of the Y1 Receptor by Neuropeptide Y Regulates the Growth of Prostate Cancer Cells Endocrinology, March 1, 2006; 147(3): 1466 - 1473. [Abstract] [Full Text] [PDF]

				M Nowicki, D Ostalska-Nowicka, and B Miskowiak Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report J. Clin. Pathol., February 1, 2006; 59(2): 150 - 152. [Abstract] [Full Text] [PDF]

				H. Tan, X. Jiang, F. Yang, Z. Li, D. Liao, J. Trial, M. J. Magera, W. Durante, X. Yang, and H. Wang Hyperhomocysteinemia inhibits post-injury reendothelialization in mice Cardiovasc Res, January 1, 2006; 69(1): 253 - 262. [Abstract] [Full Text] [PDF]

				L. Li, A.-C. Jonsson-Rylander, K. Abe, and Z. Zukowska Chronic Stress Induces Rapid Occlusion of Angioplasty-Injured Rat Carotid Artery by Activating Neuropeptide Y and Its Y1 Receptors Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2075 - 2080. [Abstract] [Full Text] [PDF]

				U. Jaakkola, T. Kuusela, T. Jartti, U. Pesonen, M. Koulu, T. Vahlberg, and J. Kallio The Leu7Pro Polymorphism of PreproNPY Is Associated with Decreased Insulin Secretion, Delayed Ghrelin Suppression, and Increased Cardiovascular Responsiveness to Norepinephrine during Oral Glucose Tolerance Test J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3646 - 3652. [Abstract] [Full Text] [PDF]

				J. Kitlinska, K. Abe, L. Kuo, J. Pons, M. Yu, L. Li, J. Tilan, L. Everhart, E. W. Lee, Z. Zukowska, et al. Differential Effects of Neuropeptide Y on the Growth and Vascularization of Neural Crest-Derived Tumors Cancer Res., March 1, 2005; 65(5): 1719 - 1728. [Abstract] [Full Text] [PDF]

				J. Troger, A. Doblinger, J. Leierer, A. Laslop, E. Schmid, B. Teuchner, M. Opatril, W. Philipp, L. Klimaschewski, K. Pfaller, et al. Secretoneurin in the Peripheral Ocular Innervation Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 647 - 654. [Abstract] [Full Text] [PDF]

				A. Barcelo, F. Barbe, E. Llompart, M. de la Pena, J. Duran-Cantolla, A. Ladaria, M. Bosch, L. Guerra, and A. G. N. Agusti Neuropeptide Y and Leptin in Patients with Obstructive Sleep Apnea Syndrome: Role of Obesity Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 183 - 187. [Abstract] [Full Text] [PDF]

				D. Miller, K. Forrester, C. Leonard, P. Salo, and R. C. Bray ACL deficiency impairs the vasoconstrictive efficacy of neuropeptide Y and phenylephrine in articular tissues: a laser speckle perfusion imaging study J Appl Physiol, January 1, 2005; 98(1): 329 - 333. [Abstract] [Full Text] [PDF]

				R. Kirchmair, M. Egger, D. H. Walter, W. Eisterer, A. Niederwanger, E. Woell, M. Nagl, M. Pedrini, T. Murayama, S. Frauscher, et al. Secretoneurin, an Angiogenic Neuropeptide, Induces Postnatal Vasculogenesis Circulation, August 31, 2004; 110(9): 1121 - 1127. [Abstract] [Full Text] [PDF]

				N. Kurimoto, Y.-S. Nan, Z.-Y. Chen, G.-G. Feng, T. Komatsu, N. Kandatsu, J. Ko, N. Kawai, and N. Ishikawa Effects of specific signal transduction inhibitors on increased permeability across rat endothelial monolayers induced by neuropeptide Y or VEGF Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H100 - H106. [Abstract] [Full Text] [PDF]

				Y. Huang, S. Wang, and T. Kelly Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast Cancer Cancer Res., April 15, 2004; 64(8): 2712 - 2716. [Abstract] [Full Text] [PDF]

				F.T. Lundy and G.J. Linden NEUROPEPTIDES AND NEUROGENIC MECHANISMS IN ORAL AND PERIODONTAL INFLAMMATION Critical Reviews in Oral Biology & Medicine, March 1, 2004; 15(2): 82 - 98. [Abstract] [Full Text] [PDF]

				R. Kirchmair, R. Gander, M. Egger, A. Hanley, M. Silver, A. Ritsch, T. Murayama, N. Kaneider, W. Sturm, M. Kearny, et al. The Neuropeptide Secretoneurin Acts as a Direct Angiogenic Cytokine In Vitro and In Vivo Circulation, February 17, 2004; 109(6): 777 - 783. [Abstract] [Full Text] [PDF]

				K. W. Dwyer, P. P. Provenzano, P. Muir, W. B. Valhmu, and R. Vanderby Jr. Blockade of the sympathetic nervous system degrades ligament in a rat MCL model J Appl Physiol, February 1, 2004; 96(2): 711 - 718. [Abstract] [Full Text] [PDF]

				A. E.G. Lomax, K. A. Sharkey, and W. R. Giles Neuropeptide Y Modulates L-Type Ca2+ Current During Heart Development Circ. Res., November 14, 2003; 93(10): 891 - 892. [Full Text] [PDF]

				L. Protas, J. Qu, and R. B. Robinson Neuropeptide Y: Neurotransmitter or Trophic Factor in the Heart? Physiology, October 1, 2003; 18(5): 181 - 185. [Abstract] [Full Text] [PDF]

				J. Kallio, U. Pesonen, U. Jaakkola, M. K. Karvonen, H. Helenius, and M. Koulu Changes in Diurnal Sympathoadrenal Balance and Pituitary Hormone Secretion in Subjects with Leu7Pro Polymorphism in the Prepro-Neuropeptide Y J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3278 - 3283. [Abstract] [Full Text] [PDF]

				C. G. Sobey Neurogenic Atherosclerosis Mediated by Neuropeptide Y: Hardening of the Evidence Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1137 - 1139. [Full Text] [PDF]

				L. Li, E. W. Lee, H. Ji, and Z. Zukowska Neuropeptide Y-Induced Acceleration of Postangioplasty Occlusion of Rat Carotid Artery Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1204 - 1210. [Abstract] [Full Text] [PDF]

				R. Q. Miao, V. Chen, L. Chao, and J. Chao Structural elements of kallistatin required for inhibition of angiogenesis Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1604 - C1613. [Abstract] [Full Text] [PDF]

				A. J. Ekstrand, R. Cao, M. Bjorndahl, S. Nystrom, A.-C. Jonsson-Rylander, H. Hassani, B. Hallberg, M. Nordlander, and Y. Cao Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing PNAS, May 13, 2003; 100(10): 6033 - 6038. [Abstract] [Full Text] [PDF]

				M. M. Berglund, P. A. Hipskind, and D. R. Gehlert Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes Exp Biol Med, March 1, 2003; 228(3): 217 - 244. [Abstract] [Full Text] [PDF]

				R. Q. Miao, J. Agata, L. Chao, and J. Chao Kallistatin is a new inhibitor of angiogenesis and tumor growth Blood, October 16, 2002; 100(9): 3245 - 3252. [Abstract] [Full Text] [PDF]

				J. Kallio, U. Pesonen, M. K. Karvonen, M. Kojima, H. Hosoda, K. Kangawa, and M. Koulu Enhanced Exercise-Induced GH Secretion in Subjects with Pro7 Substitution in the Prepro-NPY J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5348 - 5352. [Abstract] [Full Text] [PDF]

				A. J. W. Fletcher, C. M. B. Edwards, D. S. Gardner, A. L. Fowden, and D. A. Giussani Neuropeptide Y in the Sheep Fetus: Effects of Acute Hypoxemia and Dexamethasone During Late Gestation Endocrinology, November 1, 2000; 141(11): 3976 - 3982. [Abstract] [Full Text] [PDF]

				L. Niskanen, M. K. Karvonen, R. Valve, M. Koulu, U. Pesonen, M. Mercuri, R. Rauramaa, J. Töyry, M. Laakso, and M. I. J. Uusitupa Leucine 7 to Proline 7 Polymorphism in the Neuropeptide Y Gene Is Associated with Enhanced Carotid Atherosclerosis in Elderly Patients with Type 2 Diabetes and Control Subjects J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2266 - 2269. [Abstract] [Full Text]

				F. Wang, J. R. Van Brocklyn, J. P. Hobson, S. Movafagh, Z. Zukowska-Grojec, S. Milstien, and S. Spiegel Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor. POTENTIAL INVOLVEMENT IN ANGIOGENESIS J. Biol. Chem., December 10, 1999; 274(50): 35343 - 35350. [Abstract] [Full Text] [PDF]

				R. L. Meighan-Mantha, D. K. W. Hsu, Y. Guo, S. A. N. Brown, S.-L. Y. Feng, K. A. Peifley, G. F. Alberts, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, et al. The Mitogen-inducible Fn14 Gene Encodes a Type I Transmembrane Protein that Modulates Fibroblast Adhesion and Migration J. Biol. Chem., November 12, 1999; 274(46): 33166 - 33176. [Abstract] [Full Text] [PDF]

				G. Hallden, M. Hadi, H. T. Hong, and G. W. Aponte Y Receptor-mediated Induction of CD63 Transcripts, a Tetraspanin Determined To Be Necessary for Differentiation of the Intestinal Epithelial Cell Line, hBRIE 380i Cells J. Biol. Chem., September 24, 1999; 274(39): 27914 - 27924. [Abstract] [Full Text] [PDF]

				L. Protas and R. B. Robinson Neuropeptide Y contributes to innervation-dependent increase in ICa,L via ventricular Y2 receptors Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H940 - H946. [Abstract] [Full Text] [PDF]

				V. R. Young and A. M. Ajami 1999 Jonathan E. Rhoads lecture. Isotopic Metaprobes, Nutrition, and the Roads Ahead JPEN J Parenter Enteral Nutr, July 1, 1999; 23(4): 175 - 194. [Abstract] [PDF]